Antibodies help identify women protected from placental malaria

Credit: Unsplash/CC0 Public Domain

Six antibody characteristics could help scientists identify which pregnant women are at risk of placental malaria infections, finds a study published today in eLife.

Malaria infections can be devastating for pregnant mothers, particularly during their first pregnancies. If malaria parasites invade the placenta, they can starve babies of nutrition, potentially causing , preterm deliveries, stillbirths, and pregnancy loss. But not all are susceptible to placental malaria infections, and the new study may help clinicians to identify those at risk and researchers to develop new therapies to protect from malaria and related complications.

A protein made by malaria parasites called VAR2CSA allows them to attach to placental cells and invade the placenta. "Many women produce antibodies that can prevent this , and even those who have placental malaria during their first pregnancy are less likely to become infected during subsequent pregnancies because they have already developed protective antibodies," explains co-first author Dr. Elizabeth Aitken, Research Officer at the Doherty Institute, University of Melbourne, Australia. "We set out to identify the features of these antibodies that help protect women from placental infections."

In their experiments, the research team used a machine learning technique to identify naturally acquired antibody features mid pregnancy that were associated with protection from placental malaria at delivery. They analyzed 169 antibody features in 77 pregnant women from Madang, Papua New Guinea.

Of these features, they identified six that were associated with placental malaria protection. These fell into two broad groups: those related to preventing the parasites from binding to placental cells, and those that led to the destruction of infected blood cells. "Using these features, we created a model that could predict which pregnant women would develop placental malaria infections with 86% accuracy," says co-first author Timon Damelang, a Ph.D. student at the Doherty Institute.

"These results suggest it is likely there are multiple pathways to protection against placental malaria," adds co-first author Amaya Ortga-Pajares, also a Ph.D. student at the Doherty Institute.

"It will be interesting to learn whether this same combination of features can protect pregnant women from placental malaria infections in other populations," concludes senior author Professor Stephen Rogerson, Head of the Malaria Laboratory at the Doherty Institute, University of Melbourne. "This new insight is important for the development of novel vaccines or other treatments to protect pregnant women and their babies from the effects of ."

Explore further

Immune system, not COVID virus, may pose greatest risk to pregnant women

More information: Elizabeth H Aitken et al, Developing a multivariate prediction model of antibody features associated with protection of malaria-infected pregnant women from placental malaria, eLife (2021). DOI: 10.7554/eLife.65776
Journal information: eLife

Provided by eLife
Citation: Antibodies help identify women protected from placental malaria (2021, June 29) retrieved 28 September 2021 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors